Articles:

K Williams, J Chao, K Kashiwagi, T Masuko, and K Igarashi

Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit
Mol Pharmacol 1996 50: 701-708. [Abstract] [PDF]  

RT Bass, BL Buckwalter, BP Patel, MH Pausch, LA Price, J Strnad, and JR Hadcock

Identification and characterization of novel somatostatin antagonists [published erratum appears in Mol Pharmacol 1997 Jan;51(1):170]
Mol Pharmacol 1996 50: 709-715. [Abstract] [PDF]  

BY Williams, Y Wang, and A Schonbrunn

Agonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites
Mol Pharmacol 1996 50: 716-727. [Abstract] [PDF]  

DL Gustafson, HD Beall, EM Bolton, D Ross, and CA Waldren

Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones
Mol Pharmacol 1996 50: 728-735. [Abstract] [PDF]  

S Itoh, R Lu, Y Bao, JD Morrow, LJ Roberts, and VL Schuster

Structural determinants of substrates for the prostaglandin transporter PGT
Mol Pharmacol 1996 50: 736-742. [Abstract] [PDF]  

G Nickenig and TJ Murphy

Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells
Mol Pharmacol 1996 50: 743-751. [Abstract] [PDF]  

O Massot, JC Rousselle, MP Fillion, B Grimaldi, I Cloez-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen, and G Fillion

5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5- hydroxytryptamine1B/1D receptors
Mol Pharmacol 1996 50: 752-762. [Abstract] [PDF]  

L Nie, H Mogami, M Kanzaki, H Shibata, and I Kojima

Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells
Mol Pharmacol 1996 50: 763-769. [Abstract] [PDF]  

ZG Wo and RE Oswald

Ligand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding
Mol Pharmacol 1996 50: 770-780. [Abstract] [PDF]  

C Liu, X Zhuo, FJ Gonzalez, and X Ding

Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants
Mol Pharmacol 1996 50: 781-788. [Abstract] [PDF]  

AP Kennedy, KC Mangum, J Linden, and JN Wells

Covalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe
Mol Pharmacol 1996 50: 789-798. [Abstract] [PDF]  

H Canton, RB Emeson, EL Barker, JR Backstrom, JT Lu, MS Chang, and E Sanders-Bush

Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing
Mol Pharmacol 1996 50: 799-807. [Abstract] [PDF]  

SK Alahari, NM Dean, MH Fisher, R Delong, M Manoharan, KL Tivel, and RL Juliano

Inhibition of expression of the multidrug resistance-associated P- glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides
Mol Pharmacol 1996 50: 808-819. [Abstract] [PDF]  

A Oksche, R Schulein, C Rutz, U Liebenhoff, J Dickson, H Muller, M Birnbaumer, and W Rosenthal

Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function
Mol Pharmacol 1996 50: 820-828. [Abstract] [PDF]  

LA Price, J Strnad, MH Pausch, and JR Hadcock

Pharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway
Mol Pharmacol 1996 50: 829-837. [Abstract] [PDF]  

C Sissi, G Capranico, E Menta, and M Palumbo

Aza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity
Mol Pharmacol 1996 50: 838-845. [Abstract] [PDF]  

WE Jr Robinson, M Cordeiro, S Abdel-Malek, Q Jia, SA Chow, MG Reinecke, and WM Mitchell

Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase
Mol Pharmacol 1996 50: 846-855. [Abstract] [PDF]  

MC Wright, XJ Wang, M Pimenta, V Ribeiro, AJ Paine, and MC Lechner

Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid
Mol Pharmacol 1996 50: 856-863. [Abstract] [PDF]  

C Zhang, M Schmidt, C von Eichei-Streiber, and KH Jakobs

Inhibition by toxin B of inositol phosphate formation induced by G protein-coupled and tyrosine kinase receptors in N1E-115 neuroblastoma cells: involvement of Rho proteins
Mol Pharmacol 1996 50: 864-869. [Abstract] [PDF]  

KS Murthy and GM Makhlouf

Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle
Mol Pharmacol 1996 50: 870-877. [Abstract] [PDF]  

L Ramamoorthy, MC Kemp, and IR Tizard

Acemannan, a beta-(1,4)-acetylated mannan, induces nitric oxide production in macrophage cell line RAW 264.7
Mol Pharmacol 1996 50: 878-884. [Abstract] [PDF]  

BR Conklin, P Herzmark, S Ishida, TA Voyno-Yasenetskaya, Y Sun, Z Farfel, and HR Bourne

Carboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation
Mol Pharmacol 1996 50: 885-890. [Abstract] [PDF]  

S Jacobitz, MM McLaughlin, GP Livi, M Burman, and TJ Torphy

Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding
Mol Pharmacol 1996 50: 891-899. [Abstract] [PDF]  

M MacFarlane, NA Jones, C Dive, and GM Cohen

DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes
Mol Pharmacol 1996 50: 900-911. [Abstract] [PDF]  

BA McCool, JP Pin, PF Brust, MM Harpold, and DM Lovinger

Functional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells
Mol Pharmacol 1996 50: 912-922. [Abstract] [PDF]  

J Gomeza, S Mary, I Brabet, ML Parmentier, S Restituito, J Bockaert, and JP Pin

Coupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists
Mol Pharmacol 1996 50: 923-930. [Abstract] [PDF]  

S Ueno, C Zorumski, J Bracamontes, and JH Steinbach

Endogenous subunits can cause ambiguities in the pharmacology of exogenous gamma-aminobutyric acidA receptors expressed in human embryonic kidney 293 cells
Mol Pharmacol 1996 50: 931-938. [Abstract] [PDF]  

TM Norris, E Moya, IS Blagbrough, and ME Adams

Block of high-threshold calcium channels by the synthetic polyamines sFTX-3.3 and FTX-3.3
Mol Pharmacol 1996 50: 939-946. [Abstract] [PDF]  

ET Piros, PL Prather, PY Law, CJ Evans, and TG Hales

Voltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors
Mol Pharmacol 1996 50: 947-956. [Abstract] [PDF]  

EL Barker and RD Blakely

Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter
Mol Pharmacol 1996 50: 957-965. [Abstract] [PDF]  

VJ Watts and KA Neve

Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors
Mol Pharmacol 1996 50: 966-976. [Abstract] [PDF]  

SA Hjorth, K Thirstrup, and TW Schwartz

Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor
Mol Pharmacol 1996 50: 977-984. [Abstract] [PDF]  

M Merkouris, I Dragatsis, G Megaritis, G Konidakis, C Zioudrou, G Milligan, and Z Georgoussi

Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides
Mol Pharmacol 1996 50: 985-993. [Abstract] [PDF]  

PA Jr Glascott, M Tsyganskaya, E Gilfor, MA Zern, and JL Farber

The antioxidant function of the physiological content of vitamin C
Mol Pharmacol 1996 50: 994-999. [Abstract] [PDF]  

SM Yu, SF Chen, YT Lau, CM Yang, and JC Chen

Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells [published erratum appears in Mol Pharmacol 1997 Mar;51(3):533]
Mol Pharmacol 1996 50: 1000-1009. [Abstract] [PDF]  

D Yu, L Zhang, JL Eisele, D Bertrand, JP Changeux, and FF Weight

Ethanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor
Mol Pharmacol 1996 50: 1010-1016. [Abstract] [PDF]  

KA Berg, S Maayani, and WP Clarke

5-hydroxytryptamine2C receptor activation inhibits 5- hydroxytryptamine1B-like receptor function via arachidonic acid metabolism
Mol Pharmacol 1996 50: 1017-1023. [Abstract] [PDF]  

D Ragozzino, RM Woodward, Y Murata, F Eusebi, LE Overman, and R Miledi

Design and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist
Mol Pharmacol 1996 50: 1024-1030. [Abstract] [PDF]  

N Nishigaki, M Negishi, and A Ichikawa

Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist
Mol Pharmacol 1996 50: 1031-1037. [Abstract] [PDF]  

M Schmidt, C Nehls, U Rumenapp, and KH Jakobs

m3 Muscarinic receptor-induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis
Mol Pharmacol 1996 50: 1038-1046. [Abstract] [PDF]  

M Komatsu, T Schermerhorn, SG Straub, and GW Sharp

Pituitary adenylate cyclase-activating peptide, carbachol, and glucose stimulate insulin release in the absence of an increase in intracellular Ca2+
Mol Pharmacol 1996 50: 1047-1054. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.